{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT04740905_BALATON\\NCT04740905_BALATON_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Global Population",
        "text": "The global population will include all participants enrolled during the global enrollment phase (including participants enrolled in mainland China, Hong Kong, and Taiwan during that phase).",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "Global Population",
        "populationDescription": "The global population will include all participants enrolled during the global enrollment phase (including participants enrolled in mainland China, Hong Kong, and Taiwan during that phase).",
        "criteria": "Enrolled during the global enrollment phase"
      },
      {
        "id": "pop_2",
        "name": "China Subpopulation",
        "text": "The China subpopulation will include all patients enrolled in mainland China, Taiwan and Hong Kong (during both the global enrollment phase and the extended China enrollment phase).",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "China Subpopulation",
        "populationDescription": "The China subpopulation will include all patients enrolled in mainland China, Taiwan and Hong Kong (during both the global enrollment phase and the extended China enrollment phase).",
        "criteria": "Enrolled in mainland China, Taiwan, or Hong Kong during any enrollment phase"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Baseline BCVA ETDRS letter score",
        "code": "BASELINE_BCVA_ETDRS_",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Baseline BCVA ETDRS letter score",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Best-corrected visual acuity letter score at Day 1 used for stratification"
      },
      {
        "id": "char_2",
        "name": "Region",
        "code": "REGION",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Region",
        "dataType": "String",
        "instanceType": "Characteristic",
        "description": "Geographic location of the study site (United States and Canada, Asia, and the rest of the world)"
      },
      {
        "id": "char_3",
        "name": "Central Subfield Thickness",
        "code": "CENTRAL_SUBFIELD_THI",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Central Subfield Thickness",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Distance between internal limiting membrane (ILM) and Bruch’s Membrane (BM) measured in μm"
      }
    ],
    "summary": {
      "populationCount": 2,
      "characteristicCount": 3
    }
  }
}